This issue of Medical Clinics of North America provides the latest essential updates on coronary risk factors. The following key questions are answered. Are new biomarkers informative? LDL: the lower the better? How important is HDL? How much credit does triglyceride deserve? How important is family history of coronary disease? How important is age in determining coronary risk factors? Endothelial progenitor cells, menopause, and coronary risk factors? What is the role of imaging in prevention of coronary artery disease? Is genomics ready for primetime? Pediatric statinization? Individualized statinization? Polypill for some, polypill for all?
1. Cover - p. 1 2. CME Accreditation Page and Author Disclosure - p. 2 3. Forthcoming Issues - p. 3 4. Contributors - p. 4 5. Table of Contents - p. 5 6. Risk Factor Update: Old Wine in a New Bottle? - p. 6 7. Are Novel Serum Biomarkers Informative? - p. 7 8. LDL Cholesterol: The Lower the Better - p. 13 9. HDL–Cholesterol: Perfection is the Enemy of Good? - p. 21 10. Triglycerides: How Much Credit Do They Deserve? - p. 25 11. Atherosclerosis in Chronic Kidney Disease: Lessons Learned from Glycation in Diabetes - p. 33 12. “My Parents Died of Myocardial Infarction: Is that My Destiny?” - p. 38 13. Age As a Risk Factor - p. 46 14. Coronary Artery Disease in Aging Women: A Menopause of Endothelial Progenitor Cells? - p. 49 15. Imaging for Prevention - p. 56 16. Genomics: Is It Ready for Primetime? - p. 62 17. Statins Personalized - p. 68 18. Childhood Cholesterol Disorders: The Iceberg Base or Nondisease? - p. 78 19. Index - p. 87
This issue of Medical Clinics of North America provides the latest essential updates on coronary risk factors. The following key questions are answered. Are new biomarkers informative? LDL: the lower the better? How important is HDL? How much credit does triglyceride deserve? How important is family history of coronary disease? How important is age in determining coronary risk factors? Endothelial progenitor cells, menopause, and coronary risk factors? What is the role of imaging in prevention of coronary artery disease? Is genomics ready for primetime? Pediatric statinization? Individualized statinization? Polypill for some, polypill for all?
1. Cover - p. 1 2. CME Accreditation Page and Author Disclosure - p. 2 3. Forthcoming Issues - p. 3 4. Contributors - p. 4 5. Table of Contents - p. 5 6. Risk Factor Update: Old Wine in a New Bottle? - p. 6 7. Are Novel Serum Biomarkers Informative? - p. 7 8. LDL Cholesterol: The Lower the Better - p. 13 9. HDL–Cholesterol: Perfection is the Enemy of Good? - p. 21 10. Triglycerides: How Much Credit Do They Deserve? - p. 25 11. Atherosclerosis in Chronic Kidney Disease: Lessons Learned from Glycation in Diabetes - p. 33 12. “My Parents Died of Myocardial Infarction: Is that My Destiny?” - p. 38 13. Age As a Risk Factor - p. 46 14. Coronary Artery Disease in Aging Women: A Menopause of Endothelial Progenitor Cells? - p. 49 15. Imaging for Prevention - p. 56 16. Genomics: Is It Ready for Primetime? - p. 62 17. Statins Personalized - p. 68 18. Childhood Cholesterol Disorders: The Iceberg Base or Nondisease? - p. 78 19. Index - p. 87
